NCT01007656View on ClinicalTrials.gov

A Multiple-Dose Research Study on Safety Evaluation of the GD Antrodia Camphorata in 30 Healthy Adult Subjects

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

January 31, 2010

Study Completion Date

March 31, 2010

Conditions
Healthy
Interventions
DIETARY_SUPPLEMENT

GD Antrodia camphorata

Three 500mg capsules per oral dose, twice daily with an interval of 12 hours for 90 days

Trial Locations (1)

Unknown

PingTung Christian Hospital, Pingtung City

Sponsors
All Listed Sponsors
lead

Golden Biotechnology Corporation

INDUSTRY